14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today BLRX ranks #13264 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

BioLineRx Ltd. Stock Forecast NASDAQ:BLRX

$2.88 (-5.26%)

Volume: 337k

Closed: Oct 22, 2021

Hollow Logo Score: -2.795

BioLineRx Ltd. Stock Forecast

$2.88 (-5.26%)

Volume: 337k

Closed: Oct 22, 2021

Score Hollow Logo -2.795

BioLineRx Ltd. Stock Price (Quote) NASDAQ:BLRX

$2.88 ( -5.26% ) Friday, 22nd Oct 2021

Range Low Price High Price Comment
30 days $2.62 $3.15 Friday, 22nd Oct 2021 BLRX stock ended at $2.88. This is 5.26% less than the trading day before Thursday, 21st Oct 2021. During the day the stock fluctuated 4.56% from a day low at $2.85 to a day high of $2.98.
90 days $2.58 $3.38
52 weeks $1.40 $6.34

Historical BioLineRx Ltd. prices

Date Open High Low Close Volume
2021-10-22 $2.98 $2.98 $2.85 $2.88 337 372
2021-10-21 $2.85 $3.05 $2.85 $3.04 405 838
2021-10-20 $2.85 $2.92 $2.85 $2.86 157 707
2021-10-19 $2.93 $2.94 $2.88 $2.90 189 095
2021-10-18 $3.06 $3.09 $2.87 $2.90 379 171
2021-10-15 $2.91 $3.15 $2.90 $3.06 610 925
2021-10-14 $2.88 $2.97 $2.84 $2.95 417 672
2021-10-13 $2.89 $3.08 $2.69 $2.86 4 109 727
2021-10-12 $2.64 $2.70 $2.63 $2.63 153 841
2021-10-11 $2.64 $2.67 $2.62 $2.64 156 340
2021-10-08 $2.69 $2.70 $2.63 $2.64 135 754
2021-10-07 $2.70 $2.70 $2.64 $2.68 165 406
2021-10-06 $2.65 $2.71 $2.62 $2.70 179 288
2021-10-05 $2.69 $2.73 $2.63 $2.67 234 103
2021-10-04 $2.74 $2.74 $2.67 $2.70 214 787
2021-10-01 $2.72 $2.80 $2.69 $2.79 305 739
2021-09-30 $2.67 $2.76 $2.65 $2.75 143 576
2021-09-29 $2.72 $2.74 $2.68 $2.69 240 424
2021-09-28 $2.78 $2.79 $2.70 $2.71 280 763
2021-09-27 $2.89 $2.91 $2.79 $2.81 332 747
2021-09-24 $2.82 $2.92 $2.76 $2.90 444 387
2021-09-23 $2.73 $2.82 $2.73 $2.81 303 929
2021-09-22 $2.68 $2.74 $2.68 $2.73 161 377
2021-09-21 $2.66 $2.72 $2.63 $2.68 238 922
2021-09-20 $2.62 $2.70 $2.58 $2.65 427 374
2021-09-17 $2.68 $2.70 $2.62 $2.67 168 108
2021-09-16 $2.72 $2.72 $2.61 $2.67 305 257
2021-09-15 $2.81 $2.81 $2.68 $2.70 269 301
2021-09-14 $2.90 $2.90 $2.70 $2.74 378 269
2021-09-13 $2.77 $2.90 $2.73 $2.86 326 465
2021-09-10 $2.71 $2.81 $2.71 $2.77 409 958
2021-09-09 $2.71 $2.79 $2.71 $2.73 190 362
2021-09-08 $2.82 $2.82 $2.70 $2.73 302 631
2021-09-07 $2.80 $2.88 $2.75 $2.79 221 647
2021-09-03 $2.90 $2.94 $2.78 $2.78 441 315
2021-09-02 $2.91 $3.01 $2.86 $2.91 413 870
2021-09-01 $2.84 $2.94 $2.84 $2.91 265 058
2021-08-31 $2.80 $2.90 $2.78 $2.87 416 439
2021-08-30 $2.86 $2.88 $2.78 $2.80 296 983
2021-08-27 $2.87 $2.94 $2.80 $2.86 404 492
2021-08-26 $2.82 $2.89 $2.81 $2.88 341 240
2021-08-25 $2.80 $2.88 $2.78 $2.87 249 751
2021-08-24 $2.83 $2.87 $2.76 $2.82 394 113
2021-08-23 $2.75 $2.92 $2.75 $2.85 435 974
2021-08-20 $2.65 $2.83 $2.65 $2.75 381 103
2021-08-19 $2.74 $2.75 $2.65 $2.65 360 015
2021-08-18 $2.84 $2.89 $2.62 $2.76 1 467 363
2021-08-17 $2.88 $2.94 $2.77 $2.89 647 786
2021-08-16 $3.00 $3.00 $2.83 $2.85 943 993
2021-08-13 $3.02 $3.10 $3.01 $3.02 350 005

About BioLineRx Ltd.

BioLineRx Ltd BioLineRx Ltd., a clinical stage biopharmaceutical development company, engages in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. Its development pipeline consists of three primary clinical-stage therapeutic candidates, which include BL-8040, a novel peptide for the treatment of multiple cancer and hematological indications; BL-7010, a novel co-polymer for the treatment of celiac disease and glu... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT